ViroCell Biologics
Home
Conferences Careers Contact Us
Leadership Team Scientific Advisory Board Board of Directors
Innovation Research Vector design & optimization Process Development GMP manufacturing
In the News Press Releases
Home Who We Are Leadership Team Scientific Advisory Board Board of Directors What we do Innovation Research Vector design & optimization Process Development GMP manufacturing
ViroCell Biologics
Conferences Newsroom In the News Press Releases CareersContact Us

ViroCell Biologics announces pivotal partnership with Great Ormond Street

MORE
In the NewsFlorence BuchananSeptember 28, 2021CDMO, GOSH, Zayed Centre for Research, clean rooms, cell and gene therapies, 1L to 200L batch size, viral vectors, lentivirus vector, AAV vectors, CGT, gene therapy, cell therapy, UK CDMO
LinkedIn0 0 Likes
Previous

ViroCell Biologics announces pivotal partnership with Great Ormond Street

In the NewsFlorence BuchananSeptember 28, 2021CDMO, GOSH, Zayed Centre for Research, clean rooms, cell and gene therapies, 1L to 200L batch size, viral vectors, lentivirus vector, AAV vectors, CGT, gene therapy, cell therapy
Next

ViroCell Biologics and GOSH to address gene and cell therapy “logjam”

In the NewsFlorence BuchananSeptember 28, 2021CDMO, GOSH, Zayed Centre for Research, clean rooms, cell and gene therapies, 1L to 200L batch size, viral vectors, lentivirus vector, AAV vectors, CGT, gene therapy, cell therapy, Biopharma Curated, UK CDMO, Great Ormond Street Hospital, Virocell
NewsroomCareersContact UsTerms of UsePrivacy Notice

London New York

 

©2024 ViroCell Biologics, Ltd. All rights reserved.